Nuclear factor kappa B: A marker of chemotherapy for human stage IV gastric carcinoma
Author(s) -
Sheng Ye,
Youming Long,
Jian Rong,
Wen-Rui Xie
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.4739
Subject(s) - immunohistochemistry , cancer , medicine , chemotherapy , electrophoretic mobility shift assay , stage (stratigraphy) , carcinoma , survival analysis , nfkb1 , pathology , oncology , biology , gene expression , transcription factor , gene , paleontology , biochemistry
To detect the nuclear factor kappa B (NF-kappaB) condition in human stage IV gastric carcinoma patients and to explore the correlation between NF-kappaB activation and survival of these patients after chemotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom